(Automated Immunoassays)
(MSD-Multiplex ECLIA)
(SPR Biomarker Interactions)
(ImmunoCAP)
(Western Blot Imager)
(Immune Cell Cytokine Release)
(Low Volume Automated ELISA)
(Multiplex Immunoassay)
SAN DIEGO LAB
34,000 Square Feet
CRO
Immunoassay
Mass Spectrometry
USA HQ (DURHAM)
89,109 Square Feet
Discovery
Preclinical/clinal
Manufacturing
BOSTON LAB
26,453 Square Feet
Bioanalytical Services
Diagnostic Testing
EUROPEAN HQ (HAMBURG)
2,777 Square Meters
Assay Development
Validation
Sample Analysis
Global Disease Studies
MELBOURNE LAB
2,777 Square Meters
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Virology
Immunology
FIH trials & early-phase clinical trials
Central laboratory services
BRISBANE LAB
1,566 Square Meters
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Virology
Immunology
FIH trials & early-phase clinical trials
Central laboratory services
Explore the capabilities of each platform in more detail to learn which option will be best for your unique study. Our team is available for specific guidance on platform selection.
On this episode of Molecular Moments, Lynn Kamen, Ph.D., and Michelle Miller, Ph.D. DABT discuss their very different journeys to
Share This 
As therapeutic drugs have grown in complexity, so too have the bioanalysis techniques to support these products. Bioanalysis of small molecule
Share This 
Summary Jim McNally’s article, ‘Overcoming bioanalytical hurdles in the pharma and life sciences sector,’ is now available in Manufacturing Chemist magazine: Click
Share This 
Summary In an article published by Pharmaceutical Technology Europe, BioAgilytix BioAgilytix supplies its assay expertise to describe the appropriate analytical
Share This 
78,000 Square Feet of Lab and Office Space Added in the First of a Multi-Phase Expansion Durham, NC, October 19,
Share This 
Durham, NC, August 17, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in
Share This As therapeutic drugs have grown in complexity, so too have the bioanalysis techniques to support these products. Bioanalysis of small molecule
Share This 
Neoantigens are novel proteins that form on cancer cells following the development of mutations in the tumor-cell DNA. These proteins
Share This 
Cytokines are proteins released by activated cells that serve as soluble messengers binding to target cells through surface receptors, signaling
Share This 
(Automated Immunoassays)
(MSD-Multiplex ECLIA)
(SPR Biomarker Interactions)
(ImmunoCAP)
(Western Blot Imager)
(Immune Cell Cytokine Release)
(Low Volume Automated ELISA)
(Multiplex Immunoassay)
SAN DIEGO LAB
34,000 Square Feet
CRO
Immunoassay
Mass Spectrometry
USA HQ (DURHAM)
89,109 Square Feet
Discovery
Preclinical/clinal
Manufacturing
BOSTON LAB
26,453 Square Feet
Bioanalytical Services
Diagnostic Testing
EUROPEAN HQ (HAMBURG)
2,777 Square Meters
Assay Development
Validation
Sample Analysis
Global Disease Studies
MELBOURNE LAB
2,777 Square Meters
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Virology
Immunology
FIH trials & early-phase clinical trials
Central laboratory services
BRISBANE LAB
1,566 Square Meters
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Virology
Immunology
FIH trials & early-phase clinical trials
Central laboratory services
Explore the capabilities of each platform in more detail to learn which option will be best for your unique study. Our team is available for specific guidance on platform selection.
On this episode of Molecular Moments, Lynn Kamen, Ph.D., and Michelle Miller, Ph.D. DABT discuss their very different journeys to
Share This As therapeutic drugs have grown in complexity, so too have the bioanalysis techniques to support these products. Bioanalysis of small molecule
Share This Summary Jim McNally’s article, ‘Overcoming bioanalytical hurdles in the pharma and life sciences sector,’ is now available in Manufacturing Chemist magazine: Click
Share This Summary In an article published by Pharmaceutical Technology Europe, BioAgilytix BioAgilytix supplies its assay expertise to describe the appropriate analytical
Share This 78,000 Square Feet of Lab and Office Space Added in the First of a Multi-Phase Expansion Durham, NC, October 19,
Share This Durham, NC, August 17, 2022 – BioAgilytix Labs, LLC (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in
Share This As therapeutic drugs have grown in complexity, so too have the bioanalysis techniques to support these products. Bioanalysis of small molecule
Share This Neoantigens are novel proteins that form on cancer cells following the development of mutations in the tumor-cell DNA. These proteins
Share This Cytokines are proteins released by activated cells that serve as soluble messengers binding to target cells through surface receptors, signaling
Share This
Specialized Large Molecule Expertise to Cultivate Impactful Breakthroughs
Agricultural biotechnology holds strong promise to make crop production and management simpler and more efficient—but the safety of these agricultural products, both for humans and the environment, must be carefully evaluated to assess efficacy against potential risks.
Overcome large molecule complexities associated with such analysis, and speed time to market of your promising agricultural innovations, with BioAgilytix’s field-tested and proven support.
Our veteran BPM team, collectively averaging 15+ years of bench experience and comprised of over 35% Ph.D. & Masters-level scientists, will work hand in hand with our customers’ own internal scientists to navigate the complexities of large molecule bioanalysis within the area of agricultural biotechnology. Our services are tailored to supplement your scientific and regulatory knowledge with our own first hand expertise and perspectives, enabling us to solve your assay challenges quickly and optimize the potential for successful results.
It takes the right strategy and the right partner to capitalize on the growth happening in the biologics market. In this eBook, we break down eight key selection criteria for ensuring a successful partnership with a bioanalytical laboratory.
An industry leader in plant biotechnology and agriculture-related bioanalytical services, BioAgilytix offers assay development, validation, and sample analysis in support of field trials under non-GLP and GLP. We leverage innovative equipment and industry-specific expertise for transgenic plant analysis of macro-molecules in a variety of matrices including pollen, root, stem, whole plant, grain, and leaf.
We can provide accurate, high-quality data analysis to verify if transgenic crops have changed nutritionally, and protein expression testing throughout the growth stages of your crop. Defining methods, reagent qualifications, and method transfer protocols, we can support every phase of R&D for your agricultural biotechnology breakthroughs.
Our Agricultural Biotechnology Services Include:
Quality to Meet Strict Field Trial Regulatory Requirements
Explore our array of white papers, articles, and videos to gain deeper insight into our small and large molecule expertise, and to stay updated with the latest news and research coming from the field of bioanalysis.
We believe the most efficient way to successfully advance agricultural innovations is to work together; that is why BioAgilytix takes a truly consultative approach to the way we support our customers’ needs. We work to complement your own internal expertise with our focused and specialized bioanalytical capabilities – actively collaborating every step of the way to anticipate challenges and recommend solutions.
We bring our deep knowledge of the complexities that come with large molecule bioanalysis, both from a scientific and regulatory perspective, to better enable your organization to effectively navigate through the field trial phases – from early development to post-marketing surveillance. Our veteran team provides the expert guidance needed to keep your trials on track to successful results.
In fact, every field trial project we undertake is led by a seasoned Bioanalytical Project Manager (BPM) well-versed in the unique scientific and regulatory demands of agricultural biotechnology. This BPM model streamlines our bioanalysis processes at every step, enabling us to identify and solve problems before they cause timeline delays or costly setbacks.
Choosing BioAgilytix guarantees that your field trials will be performed by only the most skilled, competent, and experienced scientists. Our wealth of knowledge in agricultural biotechnology, combined with our robust technology, proven processes, and uniquely collaborative approach, enable us to deliver quality results with unequaled speed and success.
Capture the opportunity in agricultural biotechnology using the BioAgilytix team to grow your competitive advantage. Through specialized knowledge, premier laboratory facilities, and proven processes, we’ll help accelerate your field trials by delivering high-quality bioanalytical services.
2300 Englert Dr
Durham, NC, 27713
919-381-6097
Fax 919-381-6099
9050 Camino Santa Fe
San Diego, CA 92121
858-652-4600
Fax 858-652-4699
37 Kent St, Woolloongabba
Queensland, 4102, Australia
2300 Englert Dr
Durham, NC, 27713
919-381-6097
Fax 919-381-6099
9050 Camino Santa Fe
San Diego, CA 92121
858-652-4600
Fax 858-652-4699
37 Kent St,Woolloongabba
Queensland, 4102, Australia
1320 Soldiers Field Road
Boston, MA, 02135
617-456-0700
Fax 617-456-0701
1320 Soldiers Field Road
Boston, MA, 02135
617-456-0700
Fax 617-456-0701
Lademannbogen 10
22339 Hamburg Germany
+49 405267790
85 Commercial Road, Melbourne
Victoria, 3004, Australia
+61 3 9282 2184
Lademannbogen 10
22339 Hamburg Germany
+49 405267790
85 Commercial Road, Melbourne
Victoria, 3004, Australia
+61 3 9282 2184
Copyright © 2022 BioAgilytix Labs.
All rights reserved.
